Health & Pharm General

Pain Relief International Offers Sustainable Pain Relief Solution to Millions in Australia

🕔11/12/2024 11:00:00 PM

REMOVE THE PAIN - UNLEASH THE POSSIBILITIES! Pain Relief International, a registered 501(c)(3) non-profit and global leader in sustainable, drug-free pain relief technology, is proud to announce its commitment to delivering life-changing pain relief to millions of Australians suffering from chronic conditions, including migraine headaches, menstrual pain, back pain, and more.

Read Full Article

PayToMe.co and Boundarie.org Partner to Advance Global Education and Financial Inclusion

🕔11/12/2024 12:00:00 PM

PayToMe.co, an award-winning AI-driven fintech marketplace and top 1% global startup through Startupbootcamp, has announced an innovative partnership with Boundarie.

Read Full Article

Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults

🕔11/12/2024 12:44:01 AM

GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.

Read Full Article

Multimodal Protocol for Anticoagulation Monitoring in ECMO Patients: Safety Analysis of Anti-Xa and VCM Monitoring

🕔11/11/2024 6:36:47 PM

Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) AGM Chairman's Address and Investor Presentation

🕔11/8/2024 11:55:30 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address to be provided by Mr Neville Gardiner and the Investor Presentation to be provided by Dr Richard Lipscombe to shareholders.

Read Full Article

Neurizon Therapeutics Teams Up with GenieUs Genomics to Leverage Cutting-Edge Genomic Profiling in NUZ-001 Phase 1 Trial

🕔11/7/2024 1:00:00 PM

GenieUs Genomics (“GenieUs”) is excited to provide advanced genomic analysis for Neurizon Therapeutics Limited’s (“Neurizon”; ASX:NUZ; ASX:NUZOA) Phase 1 clinical trial of monepantel, now known as NUZ-001, marking an important step in understanding the genetic landscape of ALS patients.

Read Full Article

Cloud Ready and StoneFly Partner to Bring Ransomware-Proof Storage and Backup and DR to Australia

🕔11/6/2024 6:52:20 PM

Cloud Ready Solutions, a leading value-added IT distributor in Australia and the Pacific Islands, has partnered with StoneFly, Inc. (iscsi.com) a global leader in ransomware-proof enterprise storage, HCI, backup and disaster recovery (DR), cloud, and AI solutions.

Read Full Article